Loading…
avatar for Markus Decker, PhD

Markus Decker, PhD

Simcere Pharmaceutical Group
Global Head of S&E, Oncology & CGT
Markus is and experienced BD/Search & Evaluation professional with postdoctoral training and expertise in discovery and research and development in oncology, as well as possessing licensing deal experience. He has an extensive external network in the biopharmaceutical community.

Prior to joining Simcere, Markus served as Director of BD&L at CASI Pharmaceuticals, Inc. He also served in BD&L roles at Roche Partnering Oncology, and in R&D within the Cancer Immunotherapy Department at Genentech.

Markus holds a Ph.D. degree in Molecular Cell Biology / Biochemistry from the Max-Planck Institute for Molecular Cell Biology and Genetics, and a Master’s degree of Biochemistry from University of Bayreuth.